Kyntra Bio, Inc. · NASDAQ:KYNB
Kyntra Bio, Inc. shareholders
As of Sep 30, 2026, 33 institutions reported holding Kyntra Bio, Inc., 26.2% of its shares. Largest: Armistice Capital, LLC, Vanguard and Acadian Asset Management LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Kyntra Bio, Inc. | Change | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 400K | 9.9% | no change | Nov 16, 2026 |
| Vanguard | 185K | 4.6% | no change | Nov 13, 2026 |
| Acadian Asset Management LLC | 106K | 2.6% | no change | Nov 9, 2026 |
| BlackRock | 84,330 | 2.1% | no change | Nov 13, 2026 |
| Geode Capital | 41,387 | 1.0% | −1,832 | Nov 6, 2026 |
| HighTower Advisors, LLC | 39,746 | 0.98% | no change | Nov 9, 2026 |
| Renaissance Technologies | 35,281 | 0.87% | +8,200 | Nov 12, 2026 |
| Two Sigma | 31,317 | 0.77% | −8,194 | Nov 16, 2026 |
| Citadel | 24,144 | 0.60% | new | Nov 16, 2026 |
| Oppenheimer & Co Inc | 23,672 | 0.58% | new | Oct 26, 2026 |